Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Catechol-O-methyl transferase: pharmacological aspects and physiological role.

× No keyword cloud information.

103 in total

Review 1. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors: M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal: J Med Genet Date: 2002-04 Impact factor: 6.318

2. PLS modelling of structure-activity relationships of catechol O-methyltransferase inhibitors.

Authors: T Lotta; J Taskinen; R Bäckström; E Nissinen
Journal: J Comput Aided Mol Des Date: 1992-06 Impact factor: 3.686

3. Inhibitors of catechol-O-methyltransferase sensitize mice to pain.

Authors: O Kambur; R Talka; O B Ansah; V K Kontinen; A Pertovaara; E Kalso; P T Männistö
Journal: Br J Pharmacol Date: 2010-12 Impact factor: 8.739

Review 4. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors: José A Apud; Daniel R Weinberger
Journal: CNS Drugs Date: 2007 Impact factor: 5.749

5. Drinking green tea modestly reduces breast cancer risk.

Authors: Martha J Shrubsole; Wei Lu; Zhi Chen; Xiao Ou Shu; Ying Zheng; Qi Dai; Qiuyin Cai; Kai Gu; Zhi Xian Ruan; Yu-Tang Gao; Wei Zheng
Journal: J Nutr Date: 2008-12-11 Impact factor: 4.798

6. Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone.

Authors: T Keränen; A Gordin; M Karlsson; K Korpela; P J Pentikäinen; H Rita; E Schultz; L Seppälä; T Wikberg
Journal: Eur J Clin Pharmacol Date: 1994 Impact factor: 2.953

Catechol-O-methyl transferase: pharmacological aspects and physiological role.

Review 1. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

2. PLS modelling of structure-activity relationships of catechol O-methyltransferase inhibitors.

3. Inhibitors of catechol-O-methyltransferase sensitize mice to pain.

Review 4. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

5. Drinking green tea modestly reduces breast cancer risk.

6. Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone.

7. Clinical Potential of Catechol-OMethyltransferase (COMT) Inhibitors as Adjuvants in Parkinson's Disease.

8. Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

9. Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets.

10. Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form.